Additional bone scan follow‐ups were assessed in 12 patients, of which 2 showed a bone flare phenomenon according to the “2 + 2” principle in the Prostate Cancer Working Group 3 (PCWG3) criteria.4 PSMA SPECT/CT evaluation was also more accurate in these two patients. The gene discussed is FOLH1; the disease is prostate cancer.